BE889182A - Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques - Google Patents

Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques

Info

Publication number
BE889182A
BE889182A BE6/47470A BE6047470A BE889182A BE 889182 A BE889182 A BE 889182A BE 6/47470 A BE6/47470 A BE 6/47470A BE 6047470 A BE6047470 A BE 6047470A BE 889182 A BE889182 A BE 889182A
Authority
BE
Belgium
Prior art keywords
preparation
vaccines
type
viruses
therapeutic
Prior art date
Application number
BE6/47470A
Other languages
English (en)
Original Assignee
Asta Werke Ag Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Werke Ag Chem Fab filed Critical Asta Werke Ag Chem Fab
Publication of BE889182A publication Critical patent/BE889182A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661Methods of inactivation or attenuation
    • C12N2710/16663Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE6/47470A 1980-06-12 1981-06-11 Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques BE889182A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8019308 1980-06-12

Publications (1)

Publication Number Publication Date
BE889182A true BE889182A (fr) 1981-12-11

Family

ID=10514018

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47470A BE889182A (fr) 1980-06-12 1981-06-11 Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques

Country Status (7)

Country Link
US (1) US4322404A (fr)
BE (1) BE889182A (fr)
DE (1) DE3122669A1 (fr)
ES (1) ES502965A0 (fr)
FR (1) FR2484446A1 (fr)
IT (1) IT8148649A0 (fr)
NL (1) NL8102827A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
GB8305323D0 (en) * 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
NL8303501A (nl) * 1983-10-12 1985-05-01 Centraal Diergeneeskundig Inst Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.
USRE33772E (en) * 1983-10-12 1991-12-17 Centraal Diergeneeskundig Instituut Deletion mutant of a herpesvirus and vaccine containing said virus
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
US5585096A (en) * 1994-06-23 1996-12-17 Georgetown University Replication-competent herpes simplex virus mediates destruction of neoplastic cells
US6471965B1 (en) * 1994-07-27 2002-10-29 Bio-Virus Research Incorporated Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque
US5837262A (en) * 1994-07-27 1998-11-17 Bio-Virus Research Incorporated Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque
RU2225223C1 (ru) * 2002-06-14 2004-03-10 Закрытое акционерное общество Фирма "ВИТАФАРМА" Лиофилизированная антигерпетическая вакцина
EP2287288B1 (fr) * 2002-07-09 2012-11-07 Baxter International Inc. Milieu exempt de protéines animales pour la culture de cellules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR216081A1 (es) * 1976-07-02 1979-11-30 Dso Pharmachim Un metodo de preparar un mutante virosico avirulento a partir del virus de aujeszky
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung

Also Published As

Publication number Publication date
US4322404A (en) 1982-03-30
ES8303522A1 (es) 1983-02-01
FR2484446A1 (fr) 1981-12-18
DE3122669A1 (de) 1982-02-11
NL8102827A (nl) 1982-01-04
IT8148649A0 (it) 1981-06-10
ES502965A0 (es) 1983-02-01

Similar Documents

Publication Publication Date Title
BE889182A (fr) Procede de preparation de mutants nouveaux de virus d'herpes simplex type 1 ou type 2, virus mutants ainsi obtenus, vaccins prepares a partir de ceux-ci, procede pour la preparation de tels vaccins et utilisations therapeutiques et pharmacologiques
OA09198A (fr) "Comprimés de cholestyramine et procédé pour les préparer".
FR2643073B1 (fr) Procede de preparation d'extraits polyphenoliques de type flavane-3-ol purifies et extraits obtenus
HUT59600A (en) Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases
FR2565231B1 (fr) Procede de preparation d'organosilanes et d'organopolysilanes a partir d'organodisilanes
FR2558166B1 (fr) Procede de preparation d'un polymere hydrosoluble de haut poids moleculaire
EP0657438A3 (fr) Procédé pour la préparation d'alkylesulfinylbenzamides et de 1,2-benzoisothiazol-3-ones.
OA07002A (fr) Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale.
BE883274A (fr) Procede de preparation de xerogels de zircone et de silice, xerogels obtenus et leurs utilisations
BE893492A (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques prepares avec ces esters
AU7394387A (en) Sialosylcholesterol, process for its preparation, and drug for treating diseases of nervous system
BE895326A (fr) Procede de preparation d'echangeurs d'ions inorganiques a base de composes de titane, produits ainsi obtenus et leur utilisation
MA20567A1 (fr) Nouveaux derives de la thierropyridine ainsi qu'un procede pour leur preparation
FR2599971B1 (fr) Procede d'obtention de modulateurs immunologiques pour le traitement de deficiences immunitaires provoquees par des virus, et produit ainsi obtenu
BE891532A (fr) Procede de preparation d'ethyleneglycol et de ses ethers, et produits ainsi obtenus
BE880732A (fr) Procede de fabrication de vaccins contre le virus de la meningoencephalite du debut de l'ete (virus fsme) et vaccins ainsi obtenus
FR2576596B1 (fr) Procede de preparation de 4,4-dialkyl-2-azetidinones, et composes nouveaux ainsi prepares
FR2606281B1 (fr) Antigene du virus de l'hepatite b et procede pour sa production
DE3666694D1 (en) Process for producing of 4-(2-methoxyethyl)-phenylglycidyl ether and/or metoprolol
FR2584418B1 (fr) Anticorps monoclonaux contre le g-interferon, hybridomes produisant de tels anticorps, procede de preparation de tels anticorps et de tels hybridomes, leur utilisation pour differencier les gifs, et ensemble ou " kit " utilisant de tels anticorps
DZ990A1 (fr) Nouveaux dérivés du catechol ainsi qu'un procédé pour leur préparation.
ATE49885T1 (de) Avirulenter rabies-impfstoff.
AU568929B2 (en) 6-substituted prostaglandin e's and process for their preparation
AU589538B2 (en) Improved mutant vaccinia virus and process for production thereof
FR2558477B1 (fr) Procede de preparation de diphthalocyanines metalliques, produits obtenus et leur application a titre d'agents electrochromes

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ASTA-WERKE A.G. CHEMISCHE FABRIK

Effective date: 19840611